+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prostate Health Market by Product Type (Diagnostic Kits, Drugs, Imaging Systems), Indication (Benign Prostatic Hyperplasia, Prostate Cancer, Prostatitis), End User, Distribution Channel, Technology Type - Global Forecast 2025-2030- Product Image
Prostate Health Market by Product Type (Diagnostic Kits, Drugs, Imaging Systems), Indication (Benign Prostatic Hyperplasia, Prostate Cancer, Prostatitis), End User, Distribution Channel, Technology Type - Global Forecast 2025-2030- Product Image
Sale

Prostate Health Market by Product Type (Diagnostic Kits, Drugs, Imaging Systems), Indication (Benign Prostatic Hyperplasia, Prostate Cancer, Prostatitis), End User, Distribution Channel, Technology Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5639425
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The prostate health market is undergoing significant transformation as healthcare systems respond to changing demographics and advances in diagnostic and therapeutic technologies. Senior leaders across the sector face both rising challenges and unprecedented opportunities to shape clinical outcomes, cost efficiencies, and long-term strategic positioning.

Market Snapshot: Prostate Health Market Trends and Growth

The prostate health market grew from USD 57.48 billion in 2024 to USD 63.88 billion in 2025 and is expected to continue expanding at a CAGR of 10.84%, potentially reaching USD 106.61 billion by 2030. Strong market growth is underpinned by rising prevalence of prostate-related conditions, increasing adoption of early screening protocols, and a persistent emphasis on better patient care models. Accelerated technological advancements, especially in diagnostics and personalized therapies, are enhancing detection accuracy and treatment outcomes for health systems globally.

Scope & Segmentation

Designed for comprehensive strategic planning, this report provides a detailed view across every major segment and region shaping the prostate health market:

  • Product Types: Diagnostic kits, drug therapies, and imaging systems address needs from early detection to therapy monitoring and cover biopsy devices, imaging agents, PSA tests (conventional and high sensitivity), chemotherapy, hormone therapies (androgen receptor antagonists and LHRH agonists), immunotherapies, radiopharmaceuticals, and a range of imaging modalities including computed tomography, MRI, positron emission tomography, and ultrasound (transabdominal and transrectal).
  • Indications: Targeted toward benign prostatic hyperplasia, prostate cancer, and prostatitis, ensuring relevance to diverse patient treatment pathways.
  • End Users: Serving ambulatory care centers, diagnostic labs, hospitals, and specialty clinics, each with distinct integration and procurement preferences.
  • Distribution Channels: Direct tender, hospital pharmacy, online pharmacy, and retail routes cater to both clinical and patient-specific access requirements.
  • Technology Types: Advances include digital pathology (AI-based analysis, whole-slide imaging), image analysis software, molecular diagnostics, biomarker tests (PCA3 and TMPRSS2-ERG), next generation sequencing panels, and polymerase chain reaction assays (digital PCR, real time PCR) to power data-driven care models.
  • Regional Coverage: Comprehensive analysis for Americas (including US markets by state, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., UK, Germany, France, UAE, South Africa), Asia-Pacific (e.g., China, India, Japan, Australia, South Korea, Southeast Asia).
  • Company Analysis: Focused on major industry players such as Astellas Pharma Inc., Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis AG, Ferring International Center S.A., Ipsen S.A., AbbVie Inc., AstraZeneca PLC, and Merck & Co., Inc.

Key Takeaways for Senior Decision-Makers

  • Diversification in prostate health products, spanning diagnostics, drugs, and imaging systems, is driving increased adoption and workflow integration in various care settings.
  • Innovations in high-sensitivity testing and advanced imaging support earlier intervention, tailored therapies, and improved patient stratification, leading to higher standards of care.
  • Artificial intelligence and digital pathology are streamlining laboratory operations, enhancing multidisciplinary collaboration and diagnostic precision.
  • Shift toward outpatient and remote monitoring care models is facilitating value-based strategies and optimizing resource allocation for both providers and payers.
  • Regional dynamics, including infrastructure investment in the Americas, regulatory harmonization across Europe, and rapid adoption of cost-effective solutions in Asia-Pacific, demand market-specific approaches for sustainable growth.
  • Strategic partnerships among pharmaceutical, diagnostic, and technology leaders are enabling faster market entry, evidence generation, and differentiation in an increasingly competitive environment.

Tariff Impact: Navigating United States Trade Policy Changes

The upcoming United States tariff changes in 2025 are set to impact the cost and accessibility of diagnostic kits, imaging equipment, and pharmaceutical supply chains. Hospitals and laboratories should evaluate procurement strategies, considering possible sourcing shifts or domestic partnerships. Cost fluctuations in key supplies may also influence R&D and commercialization priorities, underscoring the importance of robust supplier diversification and clear value communication for payer negotiations.

Methodology & Data Sources

This report utilizes a rigorous blend of primary and secondary research, including interviews with clinicians and payers, alongside peer-reviewed publications and industry filings. Data triangulation and hybrid frameworks are applied to validate findings, ensuring that the analysis delivers actionable, reliable insights for market stakeholders.

Why This Report Matters

  • Delivers a data-backed roadmap for aligning clinical, commercial, and operational strategies with emerging prostate health trends.
  • Equips leaders with regional and segmentation insights to guide investment, partnership, and market entry decisions.
  • Supports organizational readiness by mapping both regulatory challenges and innovation trajectories within core and emerging markets.

Conclusion

This analysis clarifies how market, technological, and policy dynamics are converging on the prostate health sector. Senior decision-makers gain an authoritative foundation to support agile, evidence-based strategies in a rapidly changing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of advanced imaging modalities driving early prostate cancer detection
5.2. Expansion of telehealth and remote monitoring services for prostate health management
5.3. Emergence of personalized nutraceutical supplements tailored to prostate health needs
5.4. Integration of AI and machine learning algorithms in prostate cancer diagnostics and prognostics
5.5. Growing availability of minimally invasive focal therapies reducing post treatment side effects
5.6. Surge in direct to consumer genetic testing offerings for prostate cancer risk screening
5.7. Shifts in regulatory guidelines influencing routine prostate specific antigen screening protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Prostate Health Market, by Product Type
8.1. Introduction
8.2. Diagnostic Kits
8.2.1. Biopsy Devices
8.2.2. Imaging Agents
8.2.3. Psa Tests
8.2.3.1. Conventional
8.2.3.2. High Sensitivity
8.3. Drugs
8.3.1. Chemotherapy
8.3.2. Hormone Therapy
8.3.2.1. Androgen Receptor Antagonists
8.3.2.2. Lhrh Agonists
8.3.3. Immunotherapy
8.3.4. Radiopharmaceuticals
8.4. Imaging Systems
8.4.1. Computed Tomography
8.4.2. Magnetic Resonance Imaging
8.4.3. Positron Emission Tomography
8.4.4. Ultrasound
8.4.4.1. Transabdominal
8.4.4.2. Transrectal
9. Prostate Health Market, by Indication
9.1. Introduction
9.2. Benign Prostatic Hyperplasia
9.3. Prostate Cancer
9.4. Prostatitis
10. Prostate Health Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Specialty Clinics
11. Prostate Health Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Prostate Health Market, by Technology Type
12.1. Introduction
12.2. Digital Pathology
12.2.1. Ai Based Analysis
12.2.2. Whole Slide Imaging
12.3. Image Analysis Software
12.4. Molecular Diagnostics
12.4.1. Biomarker Tests
12.4.1.1. Pca3
12.4.1.2. Tmprss2 Erg
12.4.2. Next Generation Sequencing Panels
12.4.3. Polymerase Chain Reaction Assays
12.4.3.1. Digital Pcr
12.4.3.2. Real Time Pcr
13. Americas Prostate Health Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Prostate Health Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Prostate Health Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Astellas Pharma Inc.
16.3.2. Pfizer Inc.
16.3.3. Johnson & Johnson
16.3.4. Bayer AG
16.3.5. Novartis AG
16.3.6. Ferring International Center S.A.
16.3.7. Ipsen S.A.
16.3.8. AbbVie Inc.
16.3.9. AstraZeneca PLC
16.3.10. Merck & Co., Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PROSTATE HEALTH MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PROSTATE HEALTH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PROSTATE HEALTH MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PROSTATE HEALTH MARKET: RESEARCHAI
FIGURE 26. PROSTATE HEALTH MARKET: RESEARCHSTATISTICS
FIGURE 27. PROSTATE HEALTH MARKET: RESEARCHCONTACTS
FIGURE 28. PROSTATE HEALTH MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PROSTATE HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ANDROGEN RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ANDROGEN RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PROSTATE HEALTH MARKET SIZE, BY LHRH AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PROSTATE HEALTH MARKET SIZE, BY LHRH AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 189. CANADA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 192. CANADA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 193. CANADA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 194. CANADA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 195. CANADA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 196. CANADA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 197. CANADA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 198. CANADA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 199. CANADA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 200. CANADA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 201. CANADA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 202. CANADA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 203. CANADA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. CANADA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. CANADA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. CANADA PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. CANADA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. CANADA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. CANADA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 210. CANADA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 211. CANADA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 212. CANADA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 213. CANADA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 214. CANADA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 215. CANADA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 216. CANADA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 217. CANADA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 218. CANADA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM PROSTATE HEALTH MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Prostate Health market report include:
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Bayer AG
  • Novartis AG
  • Ferring International Center S.A.
  • Ipsen S.A.
  • AbbVie Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 106.61 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Urology Market by Product Type (Disposable Devices, Reusable Devices), Application (Benign Prostatic Hyperplasia Treatment, Cancer Diagnosis, Stone Removal), End User, Distribution Channel, Technology - Global Forecast 2025-2030 - Product Image

Urology Market by Product Type (Disposable Devices, Reusable Devices), Application (Benign Prostatic Hyperplasia Treatment, Cancer Diagnosis, Stone Removal), End User, Distribution Channel, Technology - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Prostate Cancer Diagnostics Market by Product Type (Biomarkers & Kits, Biopsy Needles, Imaging Systems), Test Type (Biopsy, Imaging Tests, Molecular Tests), End User, Technology, Application - Global Forecast 2025-2030 - Product Image

Prostate Cancer Diagnostics Market by Product Type (Biomarkers & Kits, Biopsy Needles, Imaging Systems), Test Type (Biopsy, Imaging Tests, Molecular Tests), End User, Technology, Application - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Prostate Health - Global Strategic Business Report - Product Image

Prostate Health - Global Strategic Business Report

  • Report
  • 463 Pages
  • Global
From
Prostate Cancer Diagnostics Market Report 2025 - Product Image

Prostate Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

The Prostate Health market is a subset of the pharmaceutical industry focused on the development and sale of drugs to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it are typically hormone therapy, chemotherapy, and radiation therapy. These drugs are used to reduce the size of the tumor, slow its growth, and reduce the risk of metastasis. In addition, some drugs are used to reduce the side effects of prostate cancer treatments, such as fatigue, nausea, and sexual dysfunction. The Prostate Health market is highly competitive, with many companies offering a variety of drugs to treat prostate cancer. Some of the major players in the market include AstraZeneca, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include AbbVie, Bristol-Myers Squibb, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.